Your Notifications
All done, no notifications

What is Mitral Stenosis?

Mitral Stenosis occurs when the opening of the mitral valve becomes narrowed, making it harder for blood to move from the left atrium into the left ventricle. Rheumatic heart disease is the most common cause worldwide, although mitral stenosis can also result from valve calcification, congenital abnormalities, or other less common conditions. Severe disease can lead to pulmonary hypertension, atrial fibrillation, heart failure, and other complications.

What is the Importance of Timely Treatment?

Timely treatment can help relieve breathlessness and other symptoms, reduce pressure on the heart and lungs, manage complications such as atrial fibrillation, and prevent worsening heart failure. Regular assessment helps determine whether continued monitoring, symptom or complication medications, percutaneous mitral commissurotomy, or valve surgery is appropriate based on symptoms, disease severity, valve anatomy, and overall health.

What are the Common Symptoms of Mitral Stenosis?

  • Shortness of Breath: Breathlessness may occur during physical activity and can become more noticeable as the valve narrowing progresses.
  • Fatigue: Reduced blood flow into the left ventricle may contribute to tiredness and reduced physical endurance.
  • Palpitations: An irregular or rapid heartbeat may occur, particularly when atrial fibrillation develops.
  • Reduced Exercise Tolerance: Routine activities may become increasingly difficult because of breathlessness or fatigue.
  • Swelling: Fluid retention may cause swelling of the ankles, feet, or lower legs, particularly in more advanced disease.
  • Dizziness or Chest Discomfort: Some patients may experience lightheadedness or chest discomfort, especially during exertion.

Causes and Risk Factors of Mitral Stenosis

Causes

  • Rheumatic Heart Disease: Previous rheumatic fever can cause progressive scarring and narrowing of the mitral valve and remains the most common cause worldwide.
  • Mitral Valve Calcification: Calcium deposits can progressively restrict valve movement, particularly in older adults.
  • Congenital Mitral Stenosis: Some people are born with mitral valve abnormalities that cause narrowing.
  • Autoimmune or Inflammatory Conditions: Conditions such as lupus can rarely contribute to mitral valve disease.
  • Other Structural Valve Changes: Less common abnormalities may also interfere with normal mitral valve opening.

Risk Factors

  • Previous rheumatic fever or rheumatic heart disease
  • Increasing age
  • History of valvular heart disease
  • Congenital heart abnormalities
  • Conditions associated with valve calcification
  • Certain autoimmune or inflammatory diseases
  • Previous heart valve procedure

Latest Research and Technologies in the Treatment of Mitral Stenosis in Turkey

  • Advanced cardiac centres in Turkey use multimodality imaging and catheter-based techniques to evaluate and treat mitral valve disease. Depending on the hospital and patient needs, these may include transthoracic and transesophageal echocardiography, three-dimensional echocardiography, cardiac CT and MRI, and catheter-based mitral balloon valvuloplasty. Some specialist centres also provide broader structural heart interventions and advanced cardiac imaging to support treatment planning

Treatment options for Mitral Stenosis

Percutaneous Mitral Balloon Commissurotomy (PMBC): Also known as Percutaneous Mitral Valvuloplasty (PMV), this is a catheter-based, first-line mechanical treatment to split open fused leaflets in patients with favourable rheumatic anatomy (measured via a low Wilkins score).

Mitral Valve Replacement (MVR) : The standard open-surgical option using either a mechanical or bioprosthetic valve, reserved for patients with severe calcification, distorted subvalvular apparatus, or concurrent severe mitral regurgitation.


Cost Start From 8000Explore Options

Transcatheter Mitral Valve Replacement (TMVR): This specialised procedure (such as valve-in-mitral-annular-calcification, or ViMAC) is an emerging option for elderly, high-risk patients with degenerative disease who cannot undergo open surgery.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support mitral stenosis patients in Turkey. These services include:

  • Cardiac Rehabilitation: Structured rehabilitation may help improve exercise capacity and support recovery after valve procedures.
  • Gradual Physical Activity: Increase activity according to symptoms, valve severity, heart function, and medical advice.
  • Breathing and Functional Training: Selected patients may benefit from supervised exercises to improve functional capacity.
  • Long-Term Cardiac Follow-Up: Regular cardiology and valve-clinic assessments help monitor valve function, heart rhythm, symptoms, and treatment response.
  • Medicines for mitral stenosis may include diuretics, heart-rate-controlling medicines, medicines for atrial fibrillation, and anticoagulants when indicated. These treatments can reduce symptoms and manage complications but do not reverse severe mechanical narrowing of the mitral valve. In rheumatic mitral stenosis with atrial fibrillation, anticoagulation decisions require particular consideration because thromboembolic risk is increased.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Mitral Stenosis in Turkey

Medipol Mega University Hospital: Top Doctors, and Reviews
Medipol Mega University Hospital

Istanbul, Turkey

Medipol Mega University Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • The Hospital includes 4 centers i.e. general surgery, cardiovascular surgery, oncology, and dentistry
  • Medipol patients have access to over 60,000 m2 of the gardens, 26,000 m2 of the five-storied underground parking, 100,000 m2 covered premises and 1,500 members of the stuff
  • Capacity of 470 patient beds
  • Oncology Center
  • Emergency department that can admit up to 134 patients (including general, coronary, KVC and neonatal emergency department)
  • 25 Operating rooms
  • Medipol Mega University Hospital uses the following innovative technologies- Biplane digital flat-panel angiographic system, Digital flat-panel tomosynthetic mammography, Surgical O-ARM PEROP CT Imaging system, etc.
  • Helicopters enabling the transfer of the patient at the most emergency cases
  • The Hospital creates a friendly & comfortable ambience for the patients and their relatives with terrace garden suites, normal rooms. Each room is equipped with multimedia services like TV, DVD, Internet, online access from patients bedside, Unlimited Digital Archive pacs and high-quality meal service
  • Prayer Room
  • 5-starred cafeteria/restaurant
Message Us
Medical Park Canakkale Hospital: Top Doctors, and Reviews
Medical Park Canakkale Hospital

Canakkale, Turkey

Apart from in-detail treatment procedures available, Medical Park Canakkale Hospital located in Canakkale, Turkey has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:

  • 32 patient rooms
  • 2 Operating rooms
  • 75 bed capacity
  • 24*7 Emergency Service
  • Fully equipped Neonatal Care Unit (6 Incubators)
  • In-house Pharmacy
  • Luxurious rooms for patients designed in such a way that they will feel like at 5-star hotel
  • Nurse-call system in rooms
  • Cafeteria/Restaurant
Message Us
Medical Park Fatih Hospital: Top Doctors, and Reviews
Medical Park Fatih Hospital

Istanbul, Turkey

Medical Park Fatih Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • Situated in an area of 6500 m2
  • Capacity of 84 beds
  • Emergency Clinic
  • ICU
  • Many special services, including but not limited to T.V. (all domestic and international canals are available), Internet, patient-specific diet and journals and newspapers, are offered to patients to maximize satisfaction
  • Private rooms for patients available
  • Family accommodation
  • Pharmacy
  • Laundry
  • Mobility accessible rooms
  • Parking lot
  • Prayer Room
  • Cafeteria
Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Turkey for Mitral Stenosis Treatment?

  • Experienced Cardiac Specialists: Access to cardiologists, interventional cardiologists, and cardiac surgeons experienced in managing valvular heart disease.
  • Advanced Valve Diagnostics: Major cardiac centres may offer advanced echocardiography, 3D imaging, cardiac CT, cardiac MRI, and catheter-based assessment.
  • Percutaneous Valve Procedures: Eligible patients may have access to percutaneous mitral balloon commissurotomy and other catheter-based interventions.
  • Cardiac Surgery: Specialised centres can provide mitral valve repair, commissurotomy, and valve replacement when required.
  • Multidisciplinary Heart Teams: Cardiologists, cardiac surgeons, imaging specialists, anaesthesiologists, and rehabilitation teams can collaborate on complex cases.
  • Personalised Treatment Planning: Treatment selection can consider valve anatomy, symptoms, pulmonary pressures, heart rhythm, age, associated conditions, and procedural risk.
  • Comprehensive Follow-Up: Long-term monitoring can help manage valve function, rhythm abnormalities, anticoagulation, and other complications.
  • International Patient Support: Many major Turkey hospitals assist international patients with appointments, treatment coordination, accommodation, and follow-up.

Frequently Asked Questions

Recovery depends on the severity of the condition and the treatment performed. Recovery after percutaneous balloon commissurotomy is generally shorter than recovery after open-heart surgery, while patients with untreated or chronic disease may require long-term monitoring and management.

Many people with mild or stable mitral stenosis can remain physically active. However, adjust activity based on valve narrowing severity, symptoms, heart rhythm, and pulmonary pressures. Patients with significant symptoms should receive medical guidance before increasing exercise.

Many advanced Turkey cardiac centres offer echocardiography, transesophageal and 3D echocardiography, cardiac CT and MRI, cardiac catheterisation, percutaneous mitral balloon commissurotomy, valve surgery, intensive cardiac care, and cardiac rehabilitation.

Many major Turkish hospitals have international patient departments that help overseas patients with medical records, appointments, treatment coordination, accommodation, interpretation (where available), and follow-up arrangements.

Search for a centre with experienced cardiologists, interventional cardiologists, cardiac surgeons, advanced echocardiography, catheterisation facilities, and access to a multidisciplinary heart-valve team. For complex disease, experience with the specific mitral procedure being considered is also important.

The success rate depends on the cause and severity of stenosis, valve anatomy, heart function, pulmonary pressures, heart rhythm, age, associated conditions, and the treatment performed. Generally, success rates for mitral stenosis and mitral valve treatments in Turkey range from 80% to 95%, depending on the specific procedure, patient age, and overall health status. Discuss individual outcomes with the treating heart-valve team.

Yes, many Turkish cardiac centres have experienced cardiologists, interventional cardiologists, and cardiac surgeons who evaluate and treat mitral valve disease through medical management, catheter-based procedures, and surgery.

Risks depend on the treatment. Medicines can cause side effects, and anticoagulants can increase bleeding risk. Balloon commissurotomy may involve bleeding, valve leakage, arrhythmias, blood-vessel complications, or other procedural risks. Surgery may involve bleeding, infection, arrhythmias, stroke, kidney complications, or anaesthesia-related complications.

Mitral stenosis is a heart-valve condition, not an injury. If you develop severe or rapidly worsening breathlessness, fainting, chest pain, severe palpitations, or symptoms at rest, seek prompt medical attention.

Mitral stenosis does not directly cause physical or skeletal deformities. However, advanced disease can cause pulmonary hypertension, heart failure, reduced exercise capacity, or other complications that may affect long-term physical functioning.

Yes. Breathlessness, fatigue, palpitations, reduced exercise tolerance, and limitations in daily activities can affect quality of life. Appropriate medical management, valve intervention when indicated, rehabilitation, and regular follow-up can help manage symptoms and functional limitations.

Yes. Untreated significant mitral stenosis can progressively increase pressure in the left atrium and lungs and may contribute to atrial fibrillation, pulmonary hypertension, heart failure, blood clots, and other cardiovascular complications.

Not all causes can be prevented. Preventing and appropriately treating streptococcal infections and rheumatic fever can help reduce the risk of rheumatic heart disease. Regular medical follow-up is important for people with known valve disease so providers can identify progression and complications early.

Yes. Rheumatic mitral stenosis is more common in regions and populations where rheumatic heart disease remains prevalent. Mitral stenosis related to valve calcification is more commonly seen with increasing age. People with a history of rheumatic fever, congenital valve abnormalities, or certain inflammatory conditions may also have an increased risk.

Author

Alvina Hasan
Alvina Hasan

M.Pharm

2 Year of Experience

Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.

With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven content designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.

Readers can explore her published research and articles here:

https://carcinogenesis.com/index.php/JOC/article/view/868

https://carcinogenesis.com/index.php/JOC/article/view/870

View More

Reviewer

Dr. Nityanand Tripathi
Dr. Nityanand Tripathi

Interventional Cardiologist

29 Years of Experience

With a rich experience of more than 29 years, Dr. Nityanand has gained a vast spectrum of skills and expertise in performing all types of complex cardiac procedures. He is an expert in clinical & interventional cardiology and electrophysiology. He studied his medicine (MBBS) and MD from the Institute of Medical Sciences of Banaras Hindu University, Varanasi, and later completed his DM in Cardiology from the prestigious King George Medical University, Lucknow. View More

Last Reviewed - January 2026